Healthcare Services

Global Human Immunodeficiency Virus (HIV) Diagnosis Industry Trends and Market Growth Forecast for 2026–2030

April 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Will Be The Estimated Market Valuation Of The Human Immunodeficiency Virus (HIV) Diagnosis Market By The End Of 2030?

The market for human immunodeficiency virus (hiv) diagnosis has expanded rapidly in recent years. It is projected to grow from $4.67 billion in 2025 to $5.19 billion in 2026, at a compound annual growth rate (CAGR) of 11.0%. Historically, this growth can be attributed to the global prevalence of hiv infections, government-led hiv screening programs, improved availability of rapid diagnostic kits, the expansion of diagnostic laboratory infrastructure, and increasing public health awareness initiatives.

The human immunodeficiency virus (hiv) diagnosis market size is anticipated to experience robust expansion over the coming years, projected to reach $7.4 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 9.3%. This surge during the forecast period is fueled by factors such as the increasing call for early HIV detection, a greater adoption of self-test kits, the wider deployment of point-of-care diagnostic technologies, an enhanced focus on HIV prevention and monitoring, and growing investments in infectious disease diagnostics. Prominent trends for this period encompass the rising utilization of rapid and point-of-care HIV testing, an intensified emphasis on early and routine HIV screening, a climbing demand for self-testing and home-based diagnostics, the extension of integrated HIV testing and counseling services, and a heightened focus on data-driven HIV surveillance and reporting.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15587&type=smp

What Drivers Are Shaping The Future Growth Of The Human Immunodeficiency Virus (HIV) Diagnosis Market?

The anticipated growth of the HIV diagnosis market is linked to the increasing rate of blood donation. Blood donation involves individuals voluntarily contributing blood through a procedure where a needle is inserted into a vein for collection. This surge in blood donations is a result of advancements in medical technology, enhanced community participation, and more effective strategies for recruiting and retaining donors. A greater number of people donating blood provides a larger collection of samples available for HIV testing. This expanded access to blood samples facilitates more thorough screening for HIV antibodies or antigens, thereby improving the precision and dependability of HIV diagnosis. For instance, NHS Blood and Transplant, a UK-based government agency, experienced an increase in new blood donors from 119,016 in 2022-2023 to 119,371 in 2023-2024. Consequently, the rising trend in blood donation is propelling the expansion of the HIV diagnosis market.

Which Segment Classifications Shape The Human Immunodeficiency Virus (HIV) Diagnosis Market?

The human immunodeficiency virus (hiv) diagnosis market covered in this report is segmented –

1) By Product: Consumables, Instruments, Software, Services

2) By Mode: Self-Test, Lab-Based

3) By End User: Diagnostic Laboratories, Hospitals, Research Institutions

Subsegments:

1) By Consumables: Test Kits (Rapid Hiv Test Kits, Elisa Test Kits), Reagents And Chemicals, Sample Collection Devices (Blood Collection Tubes, Lancets), Test Strips, Control And Calibration Kits, Disposable Gloves And Safety Equipment

2) By Instruments: Hiv Diagnostic Analyzers ( Automated Immunoassay Analyzers), Hiv Viral Load Testing Equipment, Cd4 Count Analyzers, Point-Of-Care Hiv Diagnostic Devices, Molecular Diagnostic Instruments ( Pcr Machines), Electrochemical And Optical Hiv Detection Instruments

3) By Software: Hiv Diagnosis Data Management Software, Electronic Health Record (Ehr) Integration Software, Hiv Test Result Interpretation Software, Laboratory Information Management Systems (Lims), Patient Monitoring And Tracking Software, Cloud-Based Hiv Diagnostic Reporting Tools

4) By Services: Diagnostic Testing Services, Hiv Testing Support Services ( Counseling, Education), Diagnostic Lab Services, Telemedicine And Remote Hiv Testing Services, Clinical Trial Services For Hiv Diagnostic Tests, Data Analytics And Interpretation Services For Hiv Testing

What Key Developments And Trends Are Impacting The Human Immunodeficiency Virus (HIV) Diagnosis Market?

Major companies within the human immunodeficiency virus (HIV) diagnosis market are prioritizing the development of long-acting, highly effective prevention and treatment alternatives, expanding accessibility through supportive reimbursement programs, and advancing innovative clinical strategies to enhance adherence and reduce new HIV infections. For instance, in June 2025, Gilead Sciences, a US-based healthcare company, obtained FDA approval for Yeztugo (lenacapavir), which is the first and only twice-yearly injectable PrEP option, marking a significant advancement in HIV prevention. Supported by Phase 3 PURPOSE 1 and PURPOSE 2 data, the drug exhibited exceptional efficacy, with ≥99.9% of participants remaining HIV-negative. This long-acting injection aims to mitigate barriers such as adherence challenges, stigma, and low awareness that currently limit PrEP usage. Yeztugo’s approval presents a promising tool to aid in reducing new HIV infections across diverse populations. Additionally, Gilead is implementing broad access initiatives, including partnerships with insurance providers, co-pay support for eligible patients, and free access for uninsured individuals via assistance programs.

Which Companies Are Expanding Their Footprint In The Human Immunodeficiency Virus (HIV) Diagnosis Market?

Major companies operating in the human immunodeficiency virus (hiv) diagnosis market are Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers, Roche Diagnostics, Becton Dickinson and Company, Hologic Inc., bioMérieux SA, Beckman Coulter Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Bio-Techne Corporation, Alere Inc., Cepheid Inc., OraSure Technologies Inc., Advanced Instruments Inc., BBI Solutions, Chembio Diagnostic Systems Inc., BioLytical Laboratories Inc., Avioq Inc., Advanced Molecular Diagnostics, Atila BioSystems Inc.

Read the full human immunodeficiency virus (hiv) diagnosis market report here:

https://www.thebusinessresearchcompany.com/report/human-immunodeficiency-virus-hiv-diagnosis-global-market-report

Which Geographic Regions Are Influencing Demand In The Human Immunodeficiency Virus (HIV) Diagnosis Market?

North America was the largest region in the HIV diagnosis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the human immunodeficiency virus (hiv) diagnosis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Human Immunodeficiency Virus (HIV) Diagnosis Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=15587&type=smp

Browse Through More Reports Similar to the Global Human Immunodeficiency Virus (HIV) Diagnosis Market 2026, By The Business Research Company

Infectious Disease Diagnostics Testing Global Market Report

https://www.thebusinessresearchcompany.com/report/infectious-disease-diagnostics-testing-global-market-report

Syphilis Immunoassay Diagnostics Global Market Report

https://www.thebusinessresearchcompany.com/report/syphilis-immunoassay-diagnostics-global-market-report

Autoimmune Disease Diagnosis Global Market Report

https://www.thebusinessresearchcompany.com/report/autoimmune-disease-diagnosis-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795